| ［1］ Bahado-Singh RO, Jodicke C. Uterine artery Doppler in first-trimester pregnancy screening［J］. Clin Obstet Gynecol,2010,53(4):879-887.［2］ Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction［J］. Prenat Diagn,2010,30(4):293-308.［3］ Myatt L, Clifton RG, Roberts JM, et al. The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population［J］. Obstet Gynecol,2012,120(4):815-822.［4］ Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis［J］. CMAJ,2008,178(6):701-711.［5］ Gebb J, Dar PE. Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction ［J］. Best Prac Res Clin Obstet Gynaecol,2011,25(3):355-366.［6］ Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia［J］. N Engl J Med,2004,350(7):672-683.［7］ Andraweera PH, Dekker GA, Roberts CT. The vascular endothelial growth factor family in adverse pregnancy outcomes［J］. Hum Reprod Update,2012,18(4):436-457.［8］ Poon LC, Kametas NA, Maiz N, et al. First-trimester prediction of hypertensive disorders in pregnancy［J］. Hypertension,2009,53(5):812-818.［9］ Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study［J］. Circulation,2013,128(19):2121-2131.［10］ Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia［J］. N Engl J Med,2004,350(7):672-683.［11］ Forest JC, Theriault S, Masse J, et al. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women［J］. Clin Chem Lab Med,2014，52(18):1169-1178.［12］ Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia［J］. Hypertension,2014,63(2):346-352.［13］ Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PLGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients［J］. Am J Obstet Gynecol,2012,206(1):51-58.［14］ Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia［J］. Circulation,2012,125(7):911-919.［15］ Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, et al. Uterine artery Doppler and sFlt-1/PLGF ratio: prognostic value in early-onset pre-eclampsia［J］. Ultrasound Obstet Gynecol,2014,43(5):525-532.［16］ Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia［J］. N Engl J Med,2006,355(10):992-1005.［17］ Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia［J］. J Matern Fetal Neonatal Med,2009,22(11):1021-1038.［18］ Gonen R, Shahar R, Grimpel YI, et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study［J］. BJOG,2008,115(12):1465-1472.［19］ Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation［J］. Ultrasound Obstet Gynecol,2007,29(2):135-140.［20］ Kenny LC, Broadhurst DI, Dunn W, et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers［J］. Hypertension,2010,56(4):741-749.（2014-06-30收稿） |
